Osimertinib vs Tofacitinib
Osimertinib vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Osimertinib and Tofacitinib.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Osimertinib — 48 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Osimertinib — C28H33N7O2; Tofacitinib — C16H20N6O.
Molecular Weight: Osimertinib — 499.6050 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Osimertinib — Small molecule; Tofacitinib — Small molecule.